Literature DB >> 20411356

Poly(ADP-ribose) metabolism in brain and its role in ischemia pathology.

Robert Piotr Strosznajder1, Kinga Czubowicz, Henryk Jesko, Joanna Benigna Strosznajder.   

Abstract

The biological roles of poly(ADP-ribose) polymers (PAR) and poly(ADP-ribosyl)ation of proteins in the central nervous system are diverse. The homeostasis of PAR orchestrated by poly(ADP-ribose) polymerase-1 (PARP-1) and poly(ADP-ribose) glycohydrolase (PARG) is crucial for cell physiology and pathology. Both enzymes are ubiquitously distributed in neurons and glia; however, they are segregated at the subcellular level. PARP-1 serves as a "nick sensor" for single- or double-stranded breaks in DNA and is involved in long and short patch base-excision repair, while PARG breaks down PAR. The stimulation of PARP-1 and PAR formation can activate proinflammatory transcription factors, including nuclear factor kappa B. However, hyperactivation of PARP-1 can result in depletion of NAD/ATP, and in PAR-dependent mitochondrial pore formation leading to release of apoptosis inducing factor and cell death. The role of PAR as a death signaling molecule in brain ischemia-reperfusion and inflammation as well as the effect of gender and aging is presented in this review. Modulating the PAR level through pharmacological or genetic intervention on PARP-1/PARG activity and gene expression should be a valuable way for neuroprotective strategy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20411356     DOI: 10.1007/s12035-010-8124-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  91 in total

1.  Poly(ADP-ribose) (PAR) polymer is a death signal.

Authors:  Shaida A Andrabi; No Soo Kim; Seong-Woon Yu; Hongmin Wang; David W Koh; Masayuki Sasaki; Judith A Klaus; Takashi Otsuka; Zhizheng Zhang; Raymond C Koehler; Patricia D Hurn; Guy G Poirier; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

2.  Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.

Authors:  Françoise Dantzer; Jean-Christophe Amé; Valérie Schreiber; Jun Nakamura; Josiane Ménissier-de Murcia; Gilbert de Murcia
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

3.  Delayed combinatorial treatment with flavopiridol and minocycline provides longer term protection for neuronal soma but not dendrites following global ischemia.

Authors:  Grace O Iyirhiaro; Tyson B Brust; Juliet Rashidian; Zohreh Galehdar; Aweis Osman; Maryam Phillips; Ruth S Slack; Brian A Macvicar; David S Park
Journal:  J Neurochem       Date:  2008-01-17       Impact factor: 5.372

4.  Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia.

Authors:  F Moroni; E Meli; F Peruginelli; A Chiarugi; A Cozzi; R Picca; P Romagnoli; R Pellicciari; D E Pellegrini-Giampietro
Journal:  Cell Death Differ       Date:  2001-09       Impact factor: 15.828

5.  Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion.

Authors:  Aaron M Hamby; Sang Won Suh; Tiina M Kauppinen; Raymond A Swanson
Journal:  Stroke       Date:  2007-02       Impact factor: 7.914

6.  Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation.

Authors:  Yue Xu; Shuang Huang; Zheng-Gang Liu; Jiahuai Han
Journal:  J Biol Chem       Date:  2006-01-30       Impact factor: 5.157

7.  Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia.

Authors:  Carsten Culmsee; Changlian Zhu; Stefan Landshamer; Barbara Becattini; Ernst Wagner; Maurizio Pellecchia; Maurizio Pellechia; Klas Blomgren; Nikolaus Plesnila
Journal:  J Neurosci       Date:  2005-11-02       Impact factor: 6.167

8.  Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats.

Authors:  K Takahashi; J H Greenberg; P Jackson; K Maclin; J Zhang
Journal:  J Cereb Blood Flow Metab       Date:  1997-11       Impact factor: 6.200

Review 9.  Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update.

Authors:  Eszter M Horvath; Csaba Szabó
Journal:  Drug News Perspect       Date:  2007-04

10.  Nicotinamide abrogates acute lung injury caused by ischaemia/reperfusion.

Authors:  C-F Su; D D Liu; S J Kao; H I Chen
Journal:  Eur Respir J       Date:  2007-05-15       Impact factor: 16.671

View more
  28 in total

Review 1.  Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives.

Authors:  Marietta Zille; Tracy D Farr; Ingo Przesdzing; Jochen Müller; Clemens Sommer; Ulrich Dirnagl; Andreas Wunder
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

Review 2.  Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.

Authors:  Amos A Fatokun; Valina L Dawson; Ted M Dawson
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 3.  Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Authors:  Nathan A Berger; Valerie C Besson; A Hamid Boulares; Alexander Bürkle; Alberto Chiarugi; Robert S Clark; Nicola J Curtin; Salvatore Cuzzocrea; Ted M Dawson; Valina L Dawson; György Haskó; Lucas Liaudet; Flavio Moroni; Pál Pacher; Peter Radermacher; Andrew L Salzman; Solomon H Snyder; Francisco Garcia Soriano; Robert P Strosznajder; Balázs Sümegi; Raymond A Swanson; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2017-03-26       Impact factor: 8.739

4.  Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway.

Authors:  Beatriz Garcia-Diaz; Emanuele Barca; Andrea Balreira; Luis C Lopez; Saba Tadesse; Sindhu Krishna; Ali Naini; Caterina Mariotti; Barbara Castellotti; Catarina M Quinzii
Journal:  Hum Mol Genet       Date:  2015-05-14       Impact factor: 6.150

Review 5.  Interplay between NAD+ and acetyl‑CoA metabolism in ischemia-induced mitochondrial pathophysiology.

Authors:  Nina Klimova; Aaron Long; Susana Scafidi; Tibor Kristian
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-24       Impact factor: 5.187

6.  Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors.

Authors:  Elisabet Wahlberg; Tobias Karlberg; Ekaterina Kouznetsova; Natalia Markova; Antonio Macchiarulo; Ann-Gerd Thorsell; Ewa Pol; Åsa Frostell; Torun Ekblad; Delal Öncü; Björn Kull; Graeme Michael Robertson; Roberto Pellicciari; Herwig Schüler; Johan Weigelt
Journal:  Nat Biotechnol       Date:  2012-02-19       Impact factor: 54.908

Review 7.  Active DNA demethylation in post-mitotic neurons: a reason for optimism.

Authors:  David P Gavin; Kayla A Chase; Rajiv P Sharma
Journal:  Neuropharmacology       Date:  2013-08-16       Impact factor: 5.250

8.  The early activation of PI3K strongly enhances the resistance of cortical neurons to hypoxic injury via the activation of downstream targets of the PI3K pathway and the normalization of the levels of PARP activity, ATP, and NAD⁺.

Authors:  Min Young Noh; Young Seo Kim; Kyu-Yong Lee; Young Joo Lee; Seung H Kim; Hyun-Jeung Yu; Seong-Ho Koh
Journal:  Mol Neurobiol       Date:  2012-12-20       Impact factor: 5.590

9.  Sirt1 in cerebral ischemia.

Authors:  Kevin B Koronowski; Miguel A Perez-Pinzon
Journal:  Brain Circ       Date:  2015-09-30

Review 10.  Multi-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism.

Authors:  Nina Klimova; Tibor Kristian
Journal:  Neurochem Res       Date:  2019-01-19       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.